Live feed08:30:00·16mPRReleasevia QuantisnowUltragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 MillionByQuantisnow·Wall Street's wire, on your screen.RARE· Ultragenyx Pharmaceutical Inc.Health Care
